HK1257401A1 - 用於治疗糖尿病和相关病症的方法和组合物 - Google Patents

用於治疗糖尿病和相关病症的方法和组合物 Download PDF

Info

Publication number
HK1257401A1
HK1257401A1 HK18116609.9A HK18116609A HK1257401A1 HK 1257401 A1 HK1257401 A1 HK 1257401A1 HK 18116609 A HK18116609 A HK 18116609A HK 1257401 A1 HK1257401 A1 HK 1257401A1
Authority
HK
Hong Kong
Prior art keywords
glutamine
diabetes
compositions
body weight
level
Prior art date
Application number
HK18116609.9A
Other languages
English (en)
Chinese (zh)
Inventor
Yutaka Niihara
Original Assignee
埃默斯医疗股份有限公司
埃默斯醫療股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48470183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1257401(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 埃默斯医疗股份有限公司, 埃默斯醫療股份有限公司 filed Critical 埃默斯医疗股份有限公司
Publication of HK1257401A1 publication Critical patent/HK1257401A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK18116609.9A 2011-11-21 2018-12-26 用於治疗糖尿病和相关病症的方法和组合物 HK1257401A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161629633P 2011-11-21 2011-11-21
US61/629,633 2011-11-21

Publications (1)

Publication Number Publication Date
HK1257401A1 true HK1257401A1 (zh) 2019-10-18

Family

ID=48470183

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116609.9A HK1257401A1 (zh) 2011-11-21 2018-12-26 用於治疗糖尿病和相关病症的方法和组合物

Country Status (10)

Country Link
US (2) US20130143968A1 (enExample)
EP (2) EP2782588B1 (enExample)
JP (4) JP6089042B2 (enExample)
CN (3) CN103945858A (enExample)
BR (1) BR112014011898A2 (enExample)
ES (1) ES2785094T3 (enExample)
HK (1) HK1257401A1 (enExample)
IN (1) IN2014KN01037A (enExample)
PH (2) PH12020550726B1 (enExample)
WO (1) WO2013077893A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
WO2003072556A1 (en) * 2001-06-27 2003-09-04 Prosidion Ltd. Glutaminyl based dpiv inhibitors
SE0201713D0 (sv) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
US20070025953A1 (en) * 2005-07-27 2007-02-01 Jones Michael R Co-therapy for diabetic conditions
CA2774197A1 (en) * 2006-04-22 2008-04-03 Harbor Biosciences, Inc. Drugs and uses to modulate inflammation, metabolic disorders and other conditions
WO2008038771A1 (en) * 2006-09-29 2008-04-03 Ajinomoto Co., Inc. Glutamine-containing composition for increasing blood flow
US20080221074A1 (en) * 2006-11-17 2008-09-11 Jaime Flores-Riveros Drug Screen and Treatment Method
EP2057905A1 (en) * 2007-11-12 2009-05-13 TIMA Foundation Composition for moderating Triglyceride and Cholesterol Levels
HUE034551T2 (en) * 2009-01-12 2018-02-28 Biokier Inc Composition and method for treatment of diabetes
NL1036746C2 (nl) * 2009-03-20 2010-09-21 Glnp Holding B.V. Kit van onderdelen bevattende l-glutamine en egcg.
MX2012003459A (es) * 2009-09-23 2012-05-22 Biokier Inc Composicion y metodo para el tratamiento de la diabetes.

Also Published As

Publication number Publication date
CN103945858A (zh) 2014-07-23
EP2782588A1 (en) 2014-10-01
JP6389495B2 (ja) 2018-09-12
BR112014011898A2 (pt) 2017-05-16
JP2014533689A (ja) 2014-12-15
JP6089042B2 (ja) 2017-03-01
PH12020550726A1 (en) 2021-06-14
US20190192463A1 (en) 2019-06-27
EP3437649A1 (en) 2019-02-06
PH12014501052B1 (en) 2020-10-09
PH12014501052A1 (en) 2014-06-30
JP2018199692A (ja) 2018-12-20
JP6550160B2 (ja) 2019-07-24
CN108354916A (zh) 2018-08-03
EP2782588A4 (en) 2015-05-20
PH12020550726B1 (en) 2022-11-09
ES2785094T3 (es) 2020-10-05
US20130143968A1 (en) 2013-06-06
IN2014KN01037A (enExample) 2015-10-09
CN108478551A (zh) 2018-09-04
JP2018115175A (ja) 2018-07-26
JP2017052766A (ja) 2017-03-16
EP2782588B1 (en) 2020-04-15
WO2013077893A1 (en) 2013-05-30

Similar Documents

Publication Publication Date Title
JP5000493B2 (ja) インスリン抵抗性を治療するための製薬組成物、同製薬組成物の調製においてベタネコール及びｎ−アセチルシステインを使用する方法及び同製薬組成物を含むキット
US6207714B1 (en) Methods and pharmaceutical preparations for improving glucose metabolism with (−)-hydroxycitric acid
CA2573000A1 (en) Composition containing statins and omega-3 fatty acids
JP3699124B2 (ja) タイプｉｉ糖尿病のピコリン酸クロム高用量治療
KR101567660B1 (ko) 진성 당뇨병을 치료하기 위한 병용제
JP6550160B2 (ja) 糖尿病及び関連症状の治療のための方法及び組成物
EP2651251B1 (en) Composition for the treatment of infertility
JP5063369B2 (ja) メグリチニド類を含有する肝臓線維化予防用医薬組成物
CA2638240C (en) Method of treating dysglycemia and glucose excursions
JP2006508995A (ja) 血清トリグリセリド値を低下させるためのＰＰＡＲαアゴニスト及びメトホルミンの使用
US20180333399A1 (en) Method of improving liver function
JP7344422B2 (ja) 糖尿病予防・治療用の医薬品組成物及びその用途
RU2664442C2 (ru) Способ снижения веса
JPWO2007007757A1 (ja) ＰＰＡＲγアゴニストを含有する医薬組成物
HK1111620A (en) Pharmaceutical composition containing ppar gamma agonist
HK1143067A (en) Pharmaceutical composition for treating dysglycemia and glucose excursions
HK1143067B (en) Pharmaceutical composition for treating dysglycemia and glucose excursions